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Abstract:  Sickle cell disease (SCD) comprises an inherited blood disorder that is life long and affects many people globally. 
Despite progress in therapy, SCA is a considerable cause of mortality and morbidity. This study was designed to measure the 
immunological and inflammatory parameters of patients with sickle cell disease (SCD) and to found if there is any role of it in the 
pathogenicity of the disease.  This study included A total of 32 patients, their ages ranged from 16 to 55 years patients with Sickle 
cell disease who have been evaluated during vaso occlusive crisis and had been followed up till they attained steady state, and 
there are 32 normal control subjects matched with patients in age and sex. In general there was elevation in all parameters the 
study were included in patients than control and particularly in crisis, despite the IgM value which was insignificantly decrease, 
but the statically significant elevation reported only in CRP, IgG, IgA. 
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1. INTRODUCTION 
The immune system is of importance in sickle cell 
disease Review of literature shows that sickle cell patients in 
other parts of the world have a variety of abnormalities in 
their specific and non-specific immune systems[1,2] C-
reactive protein (CRP) is found in the plasma, It is the most 
commonly assessed marker of acute and chronic 
inflammation [3].Increase in CRP levels is likely to vaso-
occlusion and hence blocking the blood flow to organs [4] . 
Antibodies are specialized proteins that specifically 
recognize and bind to one particular protein.antibody 
production and binding to a foreign substance or antigen, 
often is critical as a means of signaling other cells to engulf, 
kill or remove that substance from the body [4]. Total IgG 
and IgA levels are usually raised in SCD patients [5] while 
others have noted impaired in vitro function of B-
Lymphocytes [6]. 
The complement system involves a large number of plasma 
proteins that are cleaved sequentially by protease enzymes to 
generate active fragments. These function as opsonins or 
chemo attractants, and the terminal components can kill 
some pathogens directly by creating pores in their 
membranes. The cascade can be activated either  via the 
classical pathway, following binding of IgM or IgG to 
surface antigens, or the alternative pathway, in which C3b 
interacts directly with the pathogen cell surface, then 
recruiting further downstream components [7] . Deficiencies 
in the alternative pathway of the complement system and 
factor B  reported  despite of  inconsistently  demonstrate 
any deficiencies in the amount of complement components, 
but early studies did suggest a reduced functional activity of 
the alternative pathway, with lower levels of factor B  (the 
first protein recruited by C3b) and impaired opsonization of 
yeast in vitro [8,9] 
This study compared differences in the levels of, 
complements,  CRP, immunoglobulins  in SCD patients in 
painful crisis episodes and compared with their levels in 
steady state from side and healthy control from the other 
side. The aim of this study was to evaluate these 
immunological and inflammatory parameters and correlate 
their disturbance if found with the disease and its 
pathogenecity. 
 
2. MATERIALS AND METHODS 
in three subject groups namely SCD patients in painful crisis 
then follow  them up in steady state and healthy control 
subjects which age and sex matched with patients (Table 1 ) 
3ml of blood were withdrawn from each patient during 
painful episodes and also during steady state and also from 
control group subjects; the following investigations were 
done for each patient with SCD and for each control subject: 
Total immunoglobulin, complement and C-reactive protein 
(CRP). 
IgG, IgM, IgA, C3, C4 and CRP Which analyzed by 
ARCHITECT C 4000 fully automated analyzer SN 
C461520, REF 02P24-01 were evaluated by using these kits: 
IMMUNOGLOBULIN IgA A9D98-20304565/R06 
IMMUNOGLOBULIN IgG G9D99-2030-4513/R4 
IMMUNOGLOBULIN IgM M1E01-2030-3962/R3 
COMPLEMENT C3-9D96-2030-3982/R4 
COMPLEMENT C4-9D97-2030-3965/R4 
C-REACTIVE PROTEIN 8G65-2130-4143/R1 
All  the test above analyze protocol related to 
Immunoturbidimetric principle. 
 
3. RESULTS 
The results of the current study is an output from 32 SCD 
patients (14 males and 18 females), their ages range from 16 
– 55 years. Twenty two of them are SS, two are 
splenoctomized and one with splenomegaly. Ten of them are 
SF, two are splenoctomized and one with splenomegaly. The 
patients are recruited during crisis state then follow them up 
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in a steady state. There were 32 normal control subjects, 
matched with the patients in age and sex (Table 1). 
 
Table 1. Age and gender distribution of subjects 
Variables 
Subject  
Total P-value 
Case 
N=32 
Control 
N=32 
Mean age ± SD  
 30.2 + 11.5 30.1 + 11.9 9.8 + 4.2 .816 
Age-group  
16- 25 14             21.9% 14             21.9% 28           43.8% 
.986 
26-35 8                12.5% 7             10.9% 15            23.4% 
36-45 6                 9.4% 7             10.9% 13            20.3% 
46-55 4                  6.3% 4                  6.3% 8                12.5% 
Gender  
Male 14        43.8% 14         43.8% 28        43.8% 
1.000 
Female  
18        56.3% 18         56.3% 36         56.3% 
  
 As an inflammatory marker, CRP was highly elevated in 
crisis than steady state and control groups, being 4.10 mg/dl 
in crisis patients compared to 0.68 and 0.25 mg/dl in steady 
state and control groups respectively. The P-value is 0.004, 
as shown in Table 2. 
 
Table 2. Descriptive Statistical results of CRP in all groups. 
Parameters N Mean Sig. 
CRP (mg/dL) 
Crisis 32 4.10 .004 
Steady 32 0.68  
Control 32 0.25  
Total 96 1.79  
 
There is statistically significant difference in C3 level in 
patients compared to control (P-value =0.10). The difference 
was more prominent during steady state that shows the 
lowest value compared to patients during crisis and control 
group; 114, 127 and 138 mg/dl respectively. No such 
differences were reported in C4, as shown in Table 3. 
In general, immunoglobulin IgA and IgG are significantly 
higher in patients, particularly during crisis, compared to 
control group. Insignificant lowest of IgM in crisis and 
steady groups than control (P value= .481) 
 
Table 3. Descriptive Statistical results of complement and Immunoglobulin in all groups. 
Parameters N Mean Sig. 
C3(mg/dL) 
Crisis 32 127.72 .010 
Steady 32 114.03  
Control 32 138.37  
Total 96 126.48  
C4(mg/dL) Crisis 32 25.41 .703 Steady 32 23.41  
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Control 32 24.30  
Total 96 24.41  
IgA(mg/dL) 
Crisis 32 347.59 .008 
Steady 32 319.21  
Control 32 228.63  
Total 96 301.74  
IgG(mg/dL) 
Crisis 32 1833.75 .000 
Steady 32 1877.21  
Control 32 1219.37  
Total 96 1659.57  
IgM(mg/dL) 
Crisis 32 110.66 .481 
Steady 32 116.00  
Control 32 130.96  
Total 96 118.65  
 
 
4. DISCUSSION 
In this  study  patients with SCD  in crisis showed 
significantly elevated  in CRP values compared with steady 
state and healthy control groups as shown in other 
studies[10,3]. Increase in CRP levels is likely to vaso-
occlusion and hence blocking the blood flow to organs [10]. 
There is evidence that patients with sickle cell anemia have 
moderately increased in C-reactive protein during their 
symptom-free steady state and significantly increased during 
painful vaso-occlusive crisis [11,3.12].CRP level was high in 
steady state patients compare to control but this elevation 
didn’t reach to significant value. 
Patients in steady state and crisis showed significantly 
reduction in C3 values compared with healthy  control  
group  specially between steady and control while there is no 
significantly difference values in C4 among three groups, 
early work did suggest a reduced functional activity of the 
alternative  pathway, with lower levels of the active form of 
factor B (the first protein recruited by C3b) .[8] study in 
1999 did show an inverse correlation between complement 
activity and the number of crisis suffered by SCD 
patients[13].  In patients with severe variant SCD C3 were 
reduced, these differences however did not reach 
significance (P > 0.05) [14]. 
In immunoglobulin’s  levels evaluation  there is   
significantly elevated IgG values in  patients with SCD  in 
crisis and steady state groups compared with healthy control 
group and  significantly elevated  IgA values in  patients  
with SCD  in crisis group compared with healthy control and 
steady state groups while there is reduce IgM  in SCD 
patients  in steady state and crisis compared  with healthy 
control group but this reduction did not reach significance (P 
> 0.05) . 
The total spontaneous production of IgG and IgA by 
mononuclear cells is increased in asymptomatic patients with 
sickle cell disease [15,16].Chronic inflammation in sickle 
cell disease may lead to polyclonal activation of B cells[17].  
( Merck, Sharp, and Dohme, West Point, Pennsylvania) also 
reported impaired in vitro spontaneous IgM synthesis  in 
SCD patients compared with controls. Both SCD and control 
subjects had similar spontaneous IgM levels in a study done 
in Venezuela [16].  
From this study we conclude the adaptive immune response 
in SCD is impaired despite the apparent increase in 
immunoglobulin level and cell counts.  Also the SCD is a 
state of immune dysregulation that leads eventually to a 
chronic inflammatory status, during the steady state of the 
disease, with bouts of exacerbations during sickling crises, 
and we recommend for further studies to highlight the 
important points that could not be covered in this study like 
different cells functions, particularly phagocytic function and 
lymphocyte subset functions . 
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